Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold.
Foy
R
R
Stockport Health Authority, Stockport SK7 5BY. R.Foy@ed.ac.uk
So
J
J
Rous
E
E
Scarffe
J H
JH
D000553:Ambulatory Care / Q000458:organization & administration; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D002173:Cancer Care Facilities; D016527:Drug Costs; D019317:Evidence-Based Medicine; D005246:Feedback; D006292:Health Priorities; D006760:Hospitalization; D006801:Humans; D008495:Medical Oncology; D017063:Outcome Assessment, Health Care; D006113:United Kingdom